The U.S. FDA Pharmacy Compounding Advisory Committee has recommended adding six peptide substances, including BPC-157, TB-500, and MOTS-c, to the FDA's 503A Bulks List. This list allows licensed compounding pharmacies to prepare medications using these substances under specific regulations. Vanta Holdings, a longevity-focused health company, supports this move as it aligns with their strategy to enter the U.S. peptide market through a telehealth-enabled platform combined with their existing health products. While the FDA's final decision is pending, this recommendation is a key regulatory step that could facilitate Vanta's planned peptide commercialization in the U.S.
HTX successfully concluded its first TradFi "Trade to Earn" campaign, generating 63.37 million USDT in trading volume and distributing over 23,000 USDT in rewards while saving users 22,238 USDT in fees. The campaign featured innovative 24/7 mining an...
Tellus Power has introduced Tellus Energy AI, a specialized artificial intelligence model designed to optimize energy use and computing power for green AI operations. The model integrates real-time electricity pricing, load forecasting, and vehicle-t...
Tellus Power has introduced Tellus Energy AI, a specialized AI model designed to optimize energy and computing coordination for green AI operations. The model integrates real-time electricity price tracking, load forecasting, and vehicle-to-grid (V2G...
Danone published its financial report for the first half of 2026, highlighting a solid performance with a 4.2% increase in Q2 sales. The company continues to focus on health-driven products across dairy, plant-based, water, and specialized nutrition ...
Danone has published its interim financial report for the first half of 2026, highlighting a strong second quarter with sales growth of 4.2%. The report underscores the effectiveness of Danone's health-focused product portfolio in driving growth and ...
